脑部放疗，上午比下午敏感许多！
/ Y2 Q: g) r1 Y9 c- G! t# f$ A( J% O. R2 C+ e1 |5 T6 o3 l% D
5 L) M% h* S; I6 X: [7 X- Q7 wCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
3 R* S* h- N' `! f( gGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?( X; {+ ?: N8 ~) [8 H% p$ V
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
0 f& I& e8 J+ J* c, s- nSourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
% l3 U' ^6 @( C* c! _9 j8 e" N6 q& F& ^
Abstract+ N- R9 f6 _; ?' L; e. M* V; V
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.) p* o% U9 e8 f
6 [% b6 i( {/ eMETHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
% e7 h% f- s( S
- g4 t7 L" b; b7 ]RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).7 S, i0 G, ]9 U5 A! q6 S# s! p
4 {- y7 e3 k; `7 k6 w q
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.% j4 }% o) `- |! s* K
( n* n! Z; Q) h6 U6 G
|
8 [+ k2 s# R N5 Z
显身卡
